Clinical trial Recruiting at 1 site Interventional Ages 18 to 64

Managing fear of falling through floor exposure and after-fall strategies

Official title: Floor-hugging Intervention: Managing Fear of Falling Through Floor Exposure and Developing After-fall Contingency

Run by Karlstad University · NCT06815809 · Data updated 2026-11-12

This study is testing a new way to help healthy adults overcome their fear of falling by practicing getting up from the floor and building their confidence in staying balanced.

More Healthy Aging trials

Quick facts

Study typeInterventional
Ages18 Years to 64 Years
SexAll
Enrollment48 (estimated)
SponsorKarlstad University
Academic / other
Locations1 site (Karlstad, Värmland County)
StatusRecruiting
StartedFebruary 11, 2025
Main results expectedAugust 2027
Study endsOctober 2027
Registry record updatedFebruary 14, 2025
Trial IDNCT06815809 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy adults aged 18 to 64 who are fluent in Swedish or English and have a good cognitive assessment score.

Probably not a fit

Patients with neurological or musculoskeletal disorders, severe cognitive impairments, or psychiatric disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention focuses on addressing the fear of falling (FoF) by combining floor exposure with strategies to rise from the floor after a fall. It recognizes that FoF is influenced by various factors, including physical, psychological, and environmental aspects. The study aims to improve participants' confidence in their ability to maintain balance and prevent falls, ultimately enhancing their mobility and quality of life. Participants will be healthy adults aged 18 to 64 who can perform daily activities independently and have a sufficient cognitive assessment score.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce the fear of falling in participants, leading to improved mobility and quality of life.

How similar studies have gone: While there have been various interventions aimed at reducing fear of falling, this specific approach focusing on floor exposure and rising strategies is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants must be healthy adults between the ages of 18 and 64.
* Participants must be fluent in either Swedish or English.
* Participants must have a Montreal Cognitive Assessment (MoCA) score of 23 or higher.
* Participants must be able to perform activities of daily living independently.

Exclusion Criteria:

* Participants with neurological diseases (e.g., stroke, Parkinson's disease, multiple sclerosis, traumatic brain injury, etc.).
* Participants with musculoskeletal disorders (e.g., rheumatoid arthritis, sprains, strains, etc.).
* Participants with severe cognitive impairments (Montreal Cognitive Assessment score \< 23).
* Participants with psychiatric disorders (e.g., bipolar disorder, schizophrenia).
* Participants currently involved in any other exercise-based interventions that involves prolonged floor contact (e.g., yoga, martial arts, dance).

Where it's running

  • RiskLab, Karlstad University
    Karlstad, Värmland County, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.